⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Matthew McelveenMD

Hematology-Oncology · Slidell, LA 70458

NPI: 1245395573

Share:𝕏fin

30

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers90th percentile opioid prescribing

Risk indicators are statistical patterns, not allegations. Learn more

1,014

Total Claims

$496K

Drug Cost

203

Beneficiaries

$2,443

Cost/Patient

Risk Score Breakdown 30/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Opioid rate (national percentile)+5

Score components are additive. Read full methodology

Peer Comparison vs. 8,541 Hematology-Oncology providers

+562%

Opioid rate vs peers

41.5% vs 6.3% avg

-82%

Cost per patient vs peers

$2,443 vs $14K avg

-42%

Brand preference vs peers

8.5% vs 14.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

Opioid Prescribing

41.5%

Opioid Rate

421

Opioid Claims

$11K

Opioid Cost

8.1%

Long-Acting Rate

This provider's opioid prescribing rate of 41.5% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

92% generic

Brand: 86 claims · $364K

Generic: 928 claims · $132K

Patient Profile

72

Avg Age

63%

Female

2.30

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About